NEW YORK (GenomeWeb News) – As expected, Invitrogen and Applied Biosystems have completed their $6.7 billion merger today, Invitrogen announced.
 
The combined company will be called Life Technologies and will begin trading on the Nasdaq exchange under the symbol “LIFE” on Monday, Nov. 24.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: genomic analysis of Malaysian tuberculosis strain, database of bat genomes, and more.

An editorial appearing at The Scientist bemoans the high numbers of mitochondrial genome papers and suggests a different path for mitochondrial genome research.

Researchers and drug developers are excited about the potential of CRISPR-Cas9-based therapeutics, the Wall Street Journal reports.

US lawmakers want to develop a new incarnation of the National Children's Study, ScienceInsider reports.